-
Pfizer ends development of weight-loss pill danuglipron
Medical Mythbusting Commentary for April 16, 2025 Source:Pfizer ends development of weight-loss pill danuglipron
-
New recommendations to measure obesity are more helpful than using only body mass index or BMI
Medical Mythbusting Commentary for January 22, 2025 Source:BMI is wrong way to measure obesity, researchers say — here’s what they recommend instead
-
In an act that signifies panic mode, processed food manufacturers like Nestle are launching products directed towards people who are using weight-loss medications as their collective reduction in appetite is biting into sales.
Medical Mythbusting Commentary for December 24, 2024 Source:Nestle launches protein shots for U.S. weight-loss drug users
-
Metabolically-active visceral abdominal fat linked to signs of Alzheimer’s. However, given its propensity to contribute to heart disease and diabetes risk, these factors are likely a major contributing factor too.
Medical Mythbusting Commentary for December 3, 2024 Source:Belly fat linked to signs of Alzheimer’s 20 years before symptoms begin, study says
-
Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.
Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
-
Having “skinny genes” does not imply that stable weight and health are a given. Nor did the study provide conclusive proof that they play a major role in weight stability.
Medical Mythbusting Commentary for October 22, 2024 Source:Does having ‘skinny genes’ mean you can skip exercise and diet? Reference:Genotypic Variations Associated with Changes in Body Mass in Response to Endurance Training
-
How various treatments and strategies influence the physiology of the weight-loss plateau
Medical Mythbusting Commentary for April 24, 2024 Source:Here’s when your weight loss will plateau, according to science Reference:Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery
-
Mothers with obesity at greater risk of stillbirth: Canadian study
Medical Mythbusting Commentary for March 6, 2024 Source:Mothers with obesity at greater risk of stillbirth: Canadian study Reference:The impact of isolated obesity compared with obesity and other risk factors on risk of stillbirth: a retrospective cohort study
-
A new study, published in the journal Qualitative Health Research, found that yo-yo dieting or weight cycling can have long-lasting negative effects on dieters. No new ground here. Well known physiologic and mental health effects.
Medical Mythbusting Commentary for February 2, 2024 Source:‘Medically unnecessary’ diets risk a ‘lifelong struggle’ of yo-yo dieting, ‘real harm’: shocking study Reference:A Qualitative Model of Weight Cycling